Pharma IQ Members

Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.

487 results
of 45
Contributor: Joyce El Hokayem PhD
Posted: 22/08/2017
default profile icon
Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012. The number of new cases is expected to rise by about 70% over the next 2 decades.According to the World Health Organization, around 1/3 of deaths from cancer are due to the five leading behavioral and dietary risks: high body m Full Content »
Contributor: Chanice Henry
Posted: 21/08/2017
Chan
US scientists have invented a line of bioactive tissues that could be instrumental for cancer patients and wound healing, after an accident with 3D printing ink inspired the discovery. Full Content »
Contributor: David Robinson
Posted: 16/08/2017
David Robinson
As pharmaceutical industry flourishes on the back of significant R&D investment, there is growing global demand for robotics to use in drug discovery and clinical trials Full Content »
Contributor: Pharma IQ
Posted: 01/08/2017
Pharma IQ
What are the secrets to incorporating technology in compound management workflow in a way that makes sense? Perhaps more importantly, what are the benefits the pharma industry can expect to see? Full Content »
Contributor: Pharma IQ
Posted: 14/07/2017
Pharma IQ
Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be Full Content »
Contributor: Pharma IQ News
Posted: 13/07/2017
Pharma IQ News
NEW YORK, NY, June 23, 2017: The 13th Compound & Sample Management Summit is pleased to return to Philadelphia, PA, on August 28-30, 2017, with an exciting new speaker faculty and discussion topics surrounding all new emerging industry trends. The highly-anticipated 3-day summit will bring together early drug discovery experts, coming from both Full Content »
Contributor: Pharma IQ
Posted: 30/06/2017
Pharma IQ
At the recent CRISPR summit conference Pharma IQ spoke to Ben Borgo of Agilent Technologies about the future of the gene editing technique. Full Content »
Contributor: Pharma IQ
Posted: 27/06/2017
Pharma IQ
Last summer, the Zika virus outbreak triggered a worldwide health alert. Today, pathogen is a discovery priority as there is still no treatment in existence to combat the disease Full Content »
Contributor: Chanice Henry
Posted: 20/06/2017
Chan
Amid pressure to limit discovery losses and be more ethically responsible, the pharma industry is slowly bowing to the growing weight of evidence to find alternatives to testing on animals. Full Content »
Contributor: William Janzen
Posted: 19/06/2017
william comp
William P. Janzen Executive Director of Lead Discovery at Epizyme speaks to Pharma IQ about the key technology trends he has discovered that every lab should embrace. Full Content »
Posted: 08/05/2017
Biothumb
This white paper suggests an innovative R&D approach to deliver high quality products to market while reducing cost and improving ROI. Full Content »
487 results
of 45